For breast cancer, miR-483-3p and miR-138-5p showed favorable predictions against ABCB1/PTP4A2 and TMBIM6, respectively, while miR-365 and miR-331-3p mapped to ABCG2/AP2M1. This evidence concerns the gene ABCG2 and breast cancer.